Sooma Secures €5M Funding for At-home Brain Stimulation Therapies The new funding will be used to accelerate Sooma’s product development and continue the company’s rapid expansion into new and… Read more
Release Notes for Sooma Duo App and Portal Software Version 1.2.3 New features since last release Clinician portal: PDF export There is a new option to export a PDF… Read more
Reflecting on a Year of Innovation and Achievement: Sooma in 2023 Join us on a journey through the transformative year that was 2023 as we celebrate a decade of… Read more
Sooma launches system for remote clinician-monitored brain stimulation Sooma is proud to announce the launch of its new system for the remote treatment of depression, Sooma Duo. Comprised… Read more
Sooma becomes the first tDCS device manufacturer to receive European MDR certification Sooma is proud to announce that it has received certification that it conforms to the new stringent requirements… Read more
Open-Label Study Highlights Efficacy of Sooma Depression Therapy for MDD Treatment A newly published open-label study, performed at Hospital Psiquiátrico Fray Bernardino Álvarez in Mexico City, demonstrates the remarkable… Read more